Copyright © 2002 by the European Society of Cardiology.
Intrapericardial treatment of autoreactive pericardial effusion with triamcinolone. The way to avoid side effects of systemic corticosteroid therapy
Department of Internal Medicine-Cardiology, Philipps University, Marburg, Germany
revised December 3, 2001; accepted December 4, 2001
Abstract
Aims To evaluate efficacy and safety of intrapericardial treatment with the crystalloid corticosteroid triamcinolone in autoreactive pericardial effusion.
Methods and Results Two hundred and sixty consecutive patients with pericarditis/myopericarditis underwent pericardiocentesis, pericardioscopy (Storz-AF1101B1), and epicardial biopsy with pericardial fluid and tissue analyses. By polymerase chain reaction for cardiotropic viruses/bacteria in pericardial effusion and epicardial biopsies as well as by immunohistochemistry and immunocytochemistry of epicardial and endomyocardial biopsies, 84/260 patients were classified as autoreactive pericarditis and underwent intrapericardial instillation of triamcinolone (group 1: 54 patients, 50% males, mean age 48·9±14·3 years, triamcinolone 600mg.m–2.24h–1; group 2: 30 patients, 46·7% males, mean age 52·5±12·7 years, triamcinolone 300mg.m–2.24h–1). Intrapericardial administration of triamcinolone resulted in symptomatic improvement and prevented effusion recurrence in 92·6% vs 86·7% of the patients after 3 months and in 86·0% vs 82·1% after 1 year in groups 1 and 2, respectively (P>0·05). There were no treatment-related acute complications. During the follow-up, 29·6% of the patients developed transitory iatrogenic Cushing syndrome in group 1 in contrast to 13·3% in group 2 (P<0·05).
Conclusion Intrapericardial treatment of autoreactive pericarditis with 300mg.m–2.24h–1 of triamcinolone prevented recurrence of symptoms and relapse of effusion as effectively as the 600mg.m–2.24h–1 regimen, but with significantly fewer side effects. Copyright 2002 The European Society of Cardiology. Published by Elsevier Science Ltd. All rights reserved.
Key Words: Pericarditis, pericardium, pericardiocentesis, triamcinolone
f1 Correspondence: Prof Dr Bernhard Maisch, FESC, FACC, Director, Department of Internal Medicine-Cardiology, Philipps University Marburg, Baldingerstrasse 1, 35033 Marburg, Germany.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Y Kamata, M Iwamoto, Y Aoki, Y Kishaba, T Nagashima, H Nara, T Kamimura, A Tanaka, T Yoshio, H Okazaki, et al. Massive intractable pericardial effusion in a patient with systemic lupus erythematosus treated successfully with pericardial fenestration alone Lupus, November 1, 2008; 17(11): 1033 - 1035. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Imazio, A. Brucato, D. Cumetti, G. Brambilla, B. Demichelis, S. Ferro, S. Maestroni, E. Cecchi, R. Belli, G. Palmieri, et al. Corticosteroids for Recurrent Pericarditis: High Versus Low Doses: A Nonrandomized Observation Circulation, August 5, 2008; 118(6): 667 - 671. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Maisch, S. Pankuweit, K. Karatolios, and A. D. Ristic Invasive techniques--from diagnosis to treatment Rheumatology, October 1, 2006; 45(suppl_4): iv32 - iv38. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P.-Y. Levy, P.-E. Fournier, R. Charrel, D. Metras, G. Habib, and D. Raoult Molecular analysis of pericardial fluid: a 7-year experience Eur. Heart J., August 2, 2006; 27(16): 1942 - 1946. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. C. Little and G. L. Freeman Pericardial Disease Circulation, March 28, 2006; 113(12): 1622 - 1632. [Full Text] [PDF]
|
|
|
|
 |
|
 N. A. Azimi, J. G. Selter, J. D. Abott, H. S. Cabin, A. Hutner, J. Copel, and J. F. Setaro Angiosarcoma in a Pregnant Woman Presenting with Pericardial Tamponade: A Case Report and Review of the Literature Angiology, March 1, 2006; 57(2): 251 - 257. [Abstract] [PDF]
|
|
|
|
 |
|
 N Becit, Y Unlu, M Ceviz, C U Kocogullari, H Kocak, and Y Gurlertop Subxiphoid pericardiostomy in the management of pericardial effusions: case series analysis of 368 patients Heart, June 1, 2005; 91(6): 785 - 790. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Maggiolini, G. Osculati, and G. Vitale Utility and safety of diagnostic pericardiocentesis Eur. Heart J., May 2, 2005; 26(10): 1046 - 1047. [Full Text] [PDF]
|
|
|
|
|
|
B. Maisch Recurrent pericarditis: mysterious or not so mysterious? Eur. Heart J., April 1, 2005; 26(7): 631 - 633. [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Lange and L. D. Hillis Acute Pericarditis N. Engl. J. Med., November 18, 2004; 351(21): 2195 - 2202. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Raatikka, P. M. Pelkonen, E. Jokinen, and J. Karjalainen Reply J. Am. Coll. Cardiol., June 2, 2004; 43(11): 2149 - 2150. [Full Text] [PDF]
|
|
|
|
|
|
Task Force members, B. Maisch, P. M. Seferovic, A. D. Ristic, R. Erbel, R. Rienmuller, Y. Adler, W. Z. Tomkowski, G. Thiene, M. H. Yacoub, et al. Guidelines on the Diagnosis and Management of Pericardial Diseases Executive Summary: The Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology Eur. Heart J., April 1, 2004; 25(7): 587 - 610. [Full Text] [PDF]
|
|
|
|
|
|
G Permanyer-Miralda Acute pericardial disease: approach to the aetiologic diagnosis Heart, March 1, 2004; 90(3): 252 - 254. [Full Text] [PDF]
|
|
|
|
|
|
B. Maisch and A. D Ristic Practical aspects of the management of pericardial disease Heart, September 1, 2003; 89(9): 1096 - 1103. [Full Text] [PDF]
|
|
|
|
|
|
D. H. Spodick Intrapericardial treatment of persistent autoreactive pericarditis/myopericarditis and pericardial effusion Eur. Heart J., October 1, 2002; 23(19): 1481 - 1482. [Full Text] [PDF]
|
|